Resolution of the advisory board “modern treatment approaches for advanced renal cell carcinoma”

Автор: Alexeev Boris Y., Alyasova Anna V., Volkova Mariya I., Gutorov Sergey L., Matveev Vsevolod B., Popov Alexandr M., Rusakov Igor G., Kharkevich Galina Y.

Журнал: Злокачественные опухоли @malignanttumors

Рубрика: Экспертный совет

Статья в выпуске: 3 (24), 2017 года.

Бесплатный доступ

The article presents the results of the meeting of the Advisory board “Modern treatment approaches for advanced renal cell carcinoma”, held on Apr 24, 2017, with the aim to discuss current approaches to inoperable, locally advanced and advanced renal cell carcinoma. To discuss the Russian experience with lenvatinib in the routine clinical practice and get the experts' opinion on the perspectives directions of lenvatinib study in renal cell carcinoma landscape.

Advanced renal cell carcinoma, lenvatinib

Короткий адрес:

IDR: 140223055   |   DOI: 10.18027/2224-5057-2017-7-3-89-92

Статья обзорная